A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NoPatent - YesDevice | Mkt.Status | Active Ingredient | Proprietary Name | Proprietary Name (simplified) | Appl No | Dosage Form | Route | Strength | Applicant Holder | Approval date (from Drugs@FDA) | Approval Date (from Orange Book) | Link to current edition of the Orange Book | Presentation | Patents cited in the current edition of the Orange Book | Number of patents in the current edition | Last expiration date | Exclusivity on data | Type of exclusivity on data | Notes | |
2 | X | RX | INSULIN HUMAN | HUMULIN R KWIKPEN | HUMULIN | N018780 | SOLUTION | SUBCUTANEOUS | 1500 UNITS/3ML (500 UNITS/ML) | ELI LILLY AND CO | 3/31/1994 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=018780&Appl_type=N | INSULIN HUMAN (HUMULIN R KWIKPEN) SOLUTION 1500 UNITS/3ML (500 UNITS/ML) | No | 0 | - | No | ||||
3 | RX | INSULIN HUMAN | HUMULIN R | HUMULIN | N018780 | SOLUTION | SUBCUTANEOUS | 10000 UNITS/20ML (500 UNITS/ML) | ELI LILLY AND CO | 12/29/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=004&Appl_No=018780&Appl_type=N | INSULIN RECOMBINANT HUMAN (HUMULIN R) INJECTABLE 100 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
4 | RX | INSULIN LISPRO RECOMBINANT | HUMALOG | HUMALOG | N020563 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 6/14/1996 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=020563&Appl_type=N | INSULIN LISPRO RECOMBINANT (HUMALOG) INJECTABLE 100 UNITS/ML | No | 0 | - | No | |||||
5 | RX | INSULIN LISPRO RECOMBINANT | HUMALOG KWIKPEN | HUMALOG | N020563 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 9/6/2007 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=003&Appl_No=020563&Appl_type=N | INSULIN LISPRO RECOMBINANT (HUMALOG KWIKPEN) INJECTABLE 100 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
6 | RX | INSULIN ASPART RECOMBINANT | NOVOLOG | NOVOLOG | N020986 | INJECTABLE | SUBCUTANEOUS | 1000 UNITS/10ML (100 UNITS/ML) | NOVO NORDISK INC | 6/7/2000 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=020986&Appl_type=N | INSULIN ASPART RECOMBINANT (NOVOLOG) INJECTABLE 1000 UNITS/10ML (100 UNITS/ML) | No | 0 | - | No | |||||
7 | RX | INSULIN ASPART RECOMBINANT | NOVOLOG PENFILL | NOVOLOG | N020986 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 6/7/2000 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=020986&Appl_type=N | INSULIN ASPART RECOMBINANT (NOVOLOG PENFILL) INJECTABLE 300 UNITS/3ML (100 UNITS/ML) | 7762994, 8579869 | 2 | 05/23/2024 | No | |||||
8 | RX | INSULIN ASPART RECOMBINANT | NOVOLOG FLEXPEN | NOVOLOG | N020986 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 1/19/2001 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=003&Appl_No=020986&Appl_type=N | INSULIN ASPART RECOMBINANT (NOVOLOG FLEXPEN) INJECTABLE 300 UNITS/3ML (100 UNITS/ML) | 6004297, 7762994, 8579869, 9265893, RE41956, RE43834 | 6 | 09/23/2032 | No | |||||
9 | RX | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | HUMALOG MIX 75/25 | HUMALOG | N021017 | INJECTABLE | INJECTION | 75 UNITS/ML; 25 UNITS/ML | ELI LILLY AND CO | 12/22/1999 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021017&Appl_type=N | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT (HUMALOG MIX 75/25) INJECTABLE 75 UNITS/ML;25 UNITS/ML | No | 0 | - | No | |||||
10 | RX | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | HUMALOG MIX 75/25 KWIKPEN | HUMALOG | N021017 | INJECTABLE | INJECTION | 75 UNITS/ML; 25 UNITS/ML | ELI LILLY AND CO | 9/6/2007 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=021017&Appl_type=N | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT (HUMALOG MIX 75/25 KWIKPEN) INJECTABLE 75 UNITS/ML;25 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
11 | RX | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | HUMALOG MIX 50/50 | HUMALOG | N021018 | INJECTABLE | INJECTION | 50 UNITS/ML; 50 UNITS/ML | ELI LILLY AND CO | 12/22/1999 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021018&Appl_type=N | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT (HUMALOG MIX 50/50) INJECTABLE 50 UNITS/ML;50 UNITS/ML | No | 0 | - | No | |||||
12 | RX | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | HUMALOG MIX 50/50 KWIKPEN | HUMALOG | N021018 | INJECTABLE | INJECTION | 50 UNITS/ML; 50 UNITS/ML | ELI LILLY AND CO | 9/6/2007 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=021018&Appl_type=N | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT (HUMALOG MIX 50/50 KWIKPEN) INJECTABLE 50 UNITS/ML;50 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
13 | RX | INSULIN GLARGINE RECOMBINANT | LANTUS | LANTUS | N021081 | INJECTABLE | INJECTION | 100 UNITS/ML | SANOFI AVENTIS US LLC | 4/20/2000 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021081&Appl_type=N | INSULIN GLARGINE RECOMBINANT (LANTUS) INJECTABLE 100 UNITS/ML | 7476652, 7476652*PED, 7713930, 7713930*PED, 7918833, 7918833*PED | 6 | 03/23/2028 | No | |||||
14 | RX | INSULIN GLARGINE RECOMBINANT | LANTUS SOLOSTAR | LANTUS | N021081 | INJECTABLE | INJECTION | 300 UNITS/3ML (100 UNITS/ML) | SANOFI AVENTIS US LLC | 4/27/2007 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=021081&Appl_type=N | INSULIN GLARGINE RECOMBINANT (LANTUS SOLOSTAR) INJECTABLE 300 UNITS/3ML (100 UNITS/ML) | 8512297, 8556864, 8603044, 8679069, 8992486, 9011391, 9233211, 9408979, 9526844, 9533105, 9561331, 9604008, 9604009, 9610409, 9623189, 9717852, 9775954, 9827379 | 18 | 04/08/2033 | No | |||||
15 | RX | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | NOVOLOG MIX 70/30 | NOVOLOG | N021172 | INJECTABLE | SUBCUTANEOUS | 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML) | NOVO NORDISK INC | 11/1/2001 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021172&Appl_type=N | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT (NOVOLOG MIX 70/30) INJECTABLE 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML) | No | 0 | - | No | |||||
16 | RX | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | NOVOLOG MIX 70/30 FLEXPEN | NOVOLOG | N021172 | INJECTABLE | SUBCUTANEOUS | 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) | NOVO NORDISK INC | 5/3/2002 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=004&Appl_No=021172&Appl_type=N | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT (NOVOLOG MIX 70/30 FLEXPEN) INJECTABLE 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) | 6004297, 7762994, 8579869, 9265893, RE41956, RE43834 | 6 | 09/23/2032 | No | |||||
17 | RX | INSULIN DETEMIR RECOMBINANT | LEVEMIR | LEVEMIR | N021536 | INJECTABLE | SUBCUTANEOUS | 1000 UNITS/10ML (100 UNITS/ML) | NOVO NORDISK INC | 6/16/2005 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021536&Appl_type=N | INSULIN DETEMIR RECOMBINANT (LEVEMIR) INJECTABLE 1000 UNITS/10ML (100 UNITS/ML) | 5750497 | 1 | 06/16/2019 | No | |||||
18 | RX | INSULIN DETEMIR RECOMBINANT | LEVEMIR FLEXTOUCH | LEVEMIR | N021536 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 10/31/2013 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=005&Appl_No=021536&Appl_type=N | INSULIN DETEMIR RECOMBINANT (LEVEMIR FLEXTOUCH) INJECTABLE 300 UNITS/3ML (100 UNITS/ML) | 10220155, 5750497, 6899699, 7686786, 7762994, 8579869, 8672898, 8684969, 8920383, 9108002, 9132239, 9457154, 9486588, 9616180, 9687611, 9775953, 9861757, RE46363 | 18 | 2/1/2032 | No | |||||
19 | RX | INSULIN GLULISINE RECOMBINANT | APIDRA | APIDRA | N021629 | INJECTABLE | INTRAVENOUS, SUBCUTANEOUS | 1000 UNITS/10ML (100 UNITS/ML) | SANOFI AVENTIS US LLC | 4/16/2004 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=021629&Appl_type=N | INSULIN GLULISINE RECOMBINANT (APIDRA) INJECTABLE 1000 UNITS/10ML (100 UNITS/ML) | 6960561, 7452860, 7696162 | 3 | 1/25/2023 | No | |||||
20 | RX | INSULIN GLULISINE RECOMBINANT | APIDRA SOLOSTAR | APIDRA | N021629 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML | SANOFI AVENTIS US LLC | 2/24/2009 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=003&Appl_No=021629&Appl_type=N | INSULIN GLULISINE RECOMBINANT (APIDRA SOLOSTAR) INJECTABLE 300 UNITS/3ML | 6960561, 7452860, 7696162, 7918833, 8512297, 8556864, 8603044, 8679069, 8992486, 9011391, 9233211, 9408979, 9526844, 9533105, 9561331, 9604008, 9604009, 9610409, 9623189, 9717852, 9775954, 9827379 | 22 | 4/8/2033 | No | |||||
21 | RX | INSULIN RECOMBINANT HUMAN | AFREZZA | AFREZZA | N022472 | POWDER | INHALATION | 8 UNITS/INH | MANNKIND CORP | 6/27/2014 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=022472&Appl_type=N | INSULIN RECOMBINANT HUMAN (AFREZZA) POWDER 8 UNITS/INH | 6444226, 6652885, 7305986, 7464706, 7648960, 7943178, 7943572, 8119593, 8146588, 8156936, 8215300, 8258095, 8389470, 8424518, 8485180, 8499757, 8551528, 8623817, 8636001, 8729019, 8734845, 8778403, 8889099, 8912193, 8950397, 9192675, 9283193, 9339615, 9358352, 9393372, 9446133, 9511198, 9597374, 9662461, 9717689, 9943571, 10046031, 10201672 | 38 | 7/12/2032 | No | |||||
22 | RX | INSULIN RECOMBINANT HUMAN | AFREZZA | AFREZZA | N022472 | POWDER | INHALATION | 12 UNITS/INH | MANNKIND CORP | 4/17/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=003&Appl_No=022472&Appl_type=N | INSULIN RECOMBINANT HUMAN (AFREZZA) POWDER 12 UNITS/INH | 6444226, 6652885, 7305986, 7464706, 7648960, 7943178, 7943572, 8119593, 8146588, 8156936, 8215300, 8258095, 8389470, 8424518, 8485180, 8499757, 8551528, 8623817, 8636001, 8729019, 8734845, 8778403, 8889099, 8912193, 8950397, 9192675, 9283193, 9339615, 9358352, 9393372, 9446133, 9511198, 9597374, 9662461, 9717689, 9943571, 10046031, 10201672 | 38 | 7/12/2032 | No | |||||
23 | RX | INSULIN RECOMBINANT HUMAN | AFREZZA | AFREZZA | N022472 | POWDER | INHALATION | 4 UNITS/INH | MANNKIND CORP | 6/27/2014 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=022472&Appl_type=N | INSULIN RECOMBINANT HUMAN (AFREZZA) POWDER 4 UNITS/INH | 6444226, 6652885, 7305986, 7464706, 7648960, 7943178, 7943572, 8119593, 8146588, 8156936, 8215300, 8258095, 8389470, 8424518, 8485180, 8499757, 8551528, 8623817, 8636001, 8729019, 8734845, 8778403, 8889099, 8912193, 8950397, 9192675, 9283193, 9339615, 9358352, 9393372, 9446133, 9511198, 9597374, 9662461, 9717689, 9943571, 10046031, 10201672 | 38 | 7/12/2032 | No | |||||
24 | RX | INSULIN ASPART; INSULIN DEGLUDEC | RYZODEG 70/30 | RYZODEG | N203313 | SOLUTION | SUBCUTANEOUS | 90 UNITS/3ML; 210 UNITS/3ML (30 UNITS/ML; 70 UNITS/ML) | NOVO NORDISK INC | 9/25/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=203313&Appl_type=N | INSULIN ASPART; INSULIN DEGLUDEC (RYZODEG 70/30) SOLUTION 90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML) | 6899699, 7615532, 7762994, 8579869, 8672898, 8684969, 8920383, 9108002, 9132239, 9457154, 9486588, 9616180, 9687611, 9775953, 9861757, 9884094, 10220155, RE46363 | 18 | 5/1/2033 | Yes | New Patient Population; New Chemical Entity | ||||
25 | RX | INSULIN DEGLUDEC | TRESIBA | TRESIBA | N203314 | SOLUTION | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 9/25/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=203314&Appl_type=N | INSULIN DEGLUDEC (TRESIBA) SOLUTION 300 UNITS/3ML (100 UNITS/ML) | 10220155, 6899699, 7615532, 7762994, 8579869, 8672898, 8684969, 8920383, 9108002, 9132239, 9457154, 9486588, 9616180, 9687611, 9775953, 9861757, RE46363 | 17 | 2/1/2032 | Yes | New Patient Population; New Chemical Entity | ||||
26 | RX | INSULIN DEGLUDEC | TRESIBA | TRESIBA | N203314 | SOLUTION | SUBCUTANEOUS | 600 UNITS/3ML (200 UNITS/ML) | NOVO NORDISK INC | 9/25/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=203314&Appl_type=N | INSULIN DEGLUDEC (TRESIBA) SOLUTION 600 UNITS/3ML (200 UNITS/ML) | 10220155, 6899699, 7615532, 7762994, 8579869, 8672898, 8684969, 8920383, 9108002, 9132239, 9457154, 9486588, 9616180, 9687611, 9775953, 9861757, RE46363 | 17 | 2/1/2032 | Yes | New Patient Population; New Chemical Entity | ||||
27 | RX | INSULIN GLARGINE | BASAGLAR | BASAGLAR | N205692 | SOLUTION | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | ELI LILLY AND CO | 12/16/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=205692&Appl_type=N | INSULIN GLARGINE (BASAGLAR) SOLUTION 300 UNITS/3ML (100 UNITS/ML) | No | 0 | - | No | |||||
28 | RX | INSULIN LISPRO RECOMBINANT | HUMALOG KWIKPEN | HUMALOG | N205747 | SOLUTION | SUBCUTANEOUS | 200 UNITS/ML | ELI LILLY AND CO | 5/26/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=205747&Appl_type=N | INSULIN LISPRO RECOMBINANT (HUMALOG KWIKPEN) SOLUTION 200 UNITS/ML | 7291132 | 1 | 8/9/2024 | No | |||||
29 | RX | INSULIN GLARGINE RECOMBINANT | TOUJEO MAX SOLOSTAR | TOUJEO | N206538 | SOLUTION | SUBCUTANEOUS | 900 UNITS/3ML (300 UNITS/ML) | SANOFI US SERVICES INC | 2/25/2015 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=206538&Appl_type=N | INSULIN GLARGINE RECOMBINANT (TOUJEO MAX SOLOSTAR) SOLUTION 900 UNITS/3ML (300 UNITS/ML) | 7918833, 8512297, 8556864, 8603044, 8679069, 8992486, 9011391, 9233211, 9345750, 9408979, 9526844, 9533105, 9561331, 9604008, 9604009, 9610409, 9623189, 9775954, 9827379 | 19 | 5/18/2031 | No | |||||
30 | RX | INSULIN GLARGINE RECOMBINANT | TOUJEO SOLOSTAR | TOUJEO | N206538 | SOLUTION | SUBCUTANEOUS | 450 UNITS/1.5ML (300 UNITS/ML) | SANOFI US SERVICES INC | 3/26/2018 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=206538&Appl_type=N | INSULIN GLARGINE RECOMBINANT (TOUJEO SOLOSTAR) SOLUTION 450 UNITS/1.5ML (300 UNITS/ML) | 7918833, 7918833*PED, 8512297, 8556864, 8603044, 8679069, 8992486, 9011391, 9233211, 9345750, 9408979, 9526844, 9533105, 9561331, 9604008, 9604009, 9610409, 9623189, 9775954, 9827379 | 20 | 5/18/2031 | No | |||||
31 | RX | INSULIN DEGLUDEC; LIRAGLUTIDE | XULTOPHY 100/3.6 | XULTOPHY | N208583 | SOLUTION | SUBCUTANEOUS | 300 UNITS/3ML; 10.8MG/3ML (100 UNITS/ML; 3.6MG/ML) | NOVO NORDISK INC | 11/21/2016 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=208583&Appl_type=N | INSULIN DEGLUDEC; LIRAGLUTIDE (XULTOPHY 100/3.6) SOLUTION 300 UNITS/3ML;10.8MG/3ML (100 UNITS/ML;3.6MG/ML) | 10220155, 6268343, 6268343*PED, 6899699, 7615532, 7762994, 7762994*PED, 8579869, 8579869*PED, 8672898, 8684969, 8846618, 8846618*PED, 8920383, 8937042, 9108002, 9132239, 9457154, 9486588, 9616180, 9687611, 9775953, 9861757, RE46363 | 40 | 8/1/2032 | Yes | New Combination; New Chemical Entity | ||||
32 | RX | INSULIN GLARGINE; LIXISENATIDE | SOLIQUA 100/33 | SOLIQUA | N208673 | SOLUTION | SUBCUTANEOUS | 300 UNITS/3ML; 99MCG/3ML (100 UNITS/ML; 33MCG/ML) | SANOFI-AVENTIS US LLC | 11/21/2016 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=208673&Appl_type=N | INSULIN GLARGINE; LIXISENATIDE (SOLIQUA 100/33) SOLUTION 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML) | 10029011, 10117909, 7918833, 8512297, 8556864, 8603044, 8679069, 8992486, 9011391, 9233211, 9408979, 9526764, 9526844, 9533105, 9561331, 9604008, 9604009, 9610409, 9623189, 9707176, 9717852, 9775954, 9821032, 9827379, 9950039, RE45313 | 26 | 12/10/2035 | Yes | New Combination; New Chemical Entity | ||||
33 | RX | INSULIN ASPART | FIASP | FIASP | N208751 | SOLUTION | INTRAVENOUS, SUBCUTANEOUS | 1000 UNITS/10ML (100 UNITS/ML) | NOVO NORDISK INC | 9/29/2017 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=208751&Appl_type=N | INSULIN ASPART (FIASP) SOLUTION 1000 UNITS/10ML (100 UNITS/ML) | 8324157 | 1 | 06/25/2030 | Yes | New Product | ||||
34 | RX | INSULIN ASPART | FIASP FLEXTOUCH | FIASP | N208751 | SOLUTION | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 9/29/2017 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=208751&Appl_type=N | INSULIN ASPART (FIASP FLEXTOUCH) SOLUTION 300 UNITS/3ML (100 UNITS/ML) | 10220155, 6899699, 7762994, 8324157, 8579869, 8672898, 8684969, 8920383, 9108002, 9132239, 9457154, 9486588, 9616180, 9687611, 9775953, 9861757, RE46363 | 17 | 2/1/2032 | Yes | New Product | ||||
35 | RX | INSULIN LISPRO | ADMELOG | ADMELOG | N209196 | SOLUTION | INTRAVENOUS, SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | SANOFI-AVENTIS US LLC | 12/11/2017 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=003&Appl_No=209196&Appl_type=N | INSULIN LISPRO (ADMELOG) SOLUTION 300 UNITS/3ML (100 UNITS/ML) | No | 0 | - | No | |||||
36 | RX | INSULIN LISPRO | ADMELOG | ADMELOG | N209196 | SOLUTION | INTRAVENOUS, SUBCUTANEOUS | 1000 UNITS/10ML (100 UNITS/ML) | SANOFI-AVENTIS US LLC | 12/11/2017 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=209196&Appl_type=N | INSULIN LISPRO (ADMELOG) SOLUTION 1000 UNITS/10ML (100 UNITS/ML) | No | 0 | - | Yes | New Product | ||||
37 | RX | INSULIN LISPRO | ADMELOG SOLOSTAR | ADMELOG | N209196 | SOLUTION | INTRAVENOUS, SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | SANOFI-AVENTIS US LLC | 10/19/2018 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=209196&Appl_type=N | INSULIN LISPRO (ADMELOG SOLOSTAR) SOLUTION 300 UNITS/3ML (100 UNITS/ML) | 7918833, 8512297, 8556864, 8603044, 8679069, 8992486, 9011391, 9233211, 9408979, 9526844, 9533105, 9561331, 9604008, 9604009, 9610409, 9623189, 9717852, 9775954, 9827379 | 19 | 4/8/2033 | Yes | New Product | ||||
38 | X | OTC | INSULIN RECOMBINANT HUMAN | HUMULIN R PEN | HUMULIN | N018780 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 10/28/1982 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=005&Appl_No=018780&Appl_type=N | INSULIN RECOMBINANT HUMAN (HUMULIN R PEN) INJECTABLE 100 UNITS/ML | No | 0 | - | No | ||||
39 | OTC | INSULIN RECOMBINANT HUMAN | HUMULIN R | HUMULIN | N018780 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 8/6/1998 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=018780&Appl_type=N | INSULIN RECOMBINANT HUMAN (HUMULIN R) INJECTABLE 100 UNITS/ML | No | 0 | - | No | |||||
40 | OTC | INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | HUMULIN N | HUMULIN | N018781 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 10/28/1982 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=018781&Appl_type=N | INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (HUMULIN N) INJECTABLE 100 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
41 | OTC | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | HUMULIN 70/30 | HUMULIN | N019717 | INJECTABLE | INJECTION | 30 UNITS/ML; 70 UNITS/ML | ELI LILLY AND CO | 4/25/1989 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=019717&Appl_type=N | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (HUMULIN 70/30) INJECTABLE 30 UNITS/ML;70 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
42 | OTC | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | HUMULIN 70/30 PEN | HUMULIN | N019717 | INJECTABLE | INJECTION | 30 UNITS/ML; 70 UNITS/ML | ELI LILLY AND CO | 8/6/1998 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=002&Appl_No=019717&Appl_type=N | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (HUMULIN 70/30 PEN) INJECTABLE 30 UNITS/ML;70 UNITS/ML | 7291132 | 1 | 08/09/2024 | No | |||||
43 | OTC | INSULIN RECOMBINANT HUMAN | NOVOLIN R | NOVOLIN | N019938 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 6/25/1991 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=019938&Appl_type=N | INSULIN RECOMBINANT HUMAN (NOVOLIN R) INJECTABLE 100 UNITS/ML | No | 0 | - | No | https://www.walmart.com/ip/Novolin-ReliOn-Insulin-R/129783484 | ||||
44 | OTC | INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | NOVOLIN N | NOVOLIN | N019959 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 7/1/1991 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=019959&Appl_type=N | INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (NOVOLIN N) INJECTABLE 100 UNITS/ML | No | 0 | - | No | |||||
45 | OTC | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | NOVOLIN 70/30 | NOVOLIN | N019991 | INJECTABLE | INJECTION | 30 UNITS/ML; 70 UNITS/ML | NOVO NORDISK INC | 6/25/1991 | https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=019991&Appl_type=N | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN (NOVOLIN 70/30) INJECTABLE 30 UNITS/ML;70 UNITS/ML | No | 0 | - | No | |||||
46 | DISCN | INSULIN PORK | INSULIN | N017926 | INJECTABLE | INJECTION | 40 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
47 | DISCN | INSULIN PORK | REGULAR INSULIN | N017926 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
48 | DISCN | INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF | PROTAMINE ZINC INSULIN | N017928 | INJECTABLE | INJECTION | 40 UNITS/ML | BRISTOL MYERS SQUIBB CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
49 | DISCN | INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF | PROTAMINE ZINC INSULIN | N017928 | INJECTABLE | INJECTION | 100 UNITS/ML | BRISTOL MYERS SQUIBB CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
50 | DISCN | INSULIN SUSP ISOPHANE BEEF | NPH INSULIN | N017929 | INJECTABLE | INJECTION | 40 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
51 | DISCN | INSULIN SUSP ISOPHANE BEEF | NPH INSULIN | N017929 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
52 | DISCN | INSULIN PORK | ILETIN I | N017931 | INJECTABLE | INJECTION | 500 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
53 | DISCN | INSULIN SUSP PROTAMINE ZINC BEEF/PORK | PROTAMINE ZINC & ILETIN I (BEEF-PORK) | N017932 | INJECTABLE | INJECTION | 40 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
54 | DISCN | INSULIN SUSP PROTAMINE ZINC BEEF/PORK | PROTAMINE ZINC & ILETIN I (BEEF-PORK) | N017932 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
55 | DISCN | INSULIN SUSP ISOPHANE BEEF/PORK | NPH ILETIN I (BEEF-PORK) | N017936 | INJECTABLE | INJECTION | 40 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
56 | DISCN | INSULIN SUSP ISOPHANE BEEF/PORK | NPH ILETIN I (BEEF-PORK) | N017936 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
57 | DISCN | INSULIN ZINC SUSP PROMPT BEEF | SEMILENTE INSULIN | N017996 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
58 | DISCN | INSULIN ZINC SUSP EXTENDED BEEF | ULTRALENTE INSULIN | N017997 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
59 | DISCN | INSULIN ZINC SUSP BEEF | LENTE INSULIN | N017998 | INJECTABLE | INJECTION | 40 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
60 | DISCN | INSULIN ZINC SUSP BEEF | LENTE INSULIN | N017998 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
61 | DISCN | INSULIN PURIFIED PORK | VELOSULIN | N018193 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
62 | DISCN | INSULIN SUSP ISOPHANE PURIFIED PORK | INSULIN INSULATARD NPH NORDISK | N018194 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
63 | DISCN | INSULIN PURIFIED PORK; INSULIN SUSP ISOPHANE PURIFIED PORK | INSULIN NORDISK MIXTARD (PORK) | N018195 | INJECTABLE | INJECTION | 30 UNITS/ML; 70 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
64 | DISCN | INSULIN PURIFIED PORK | ILETIN II | N018344 | INJECTABLE | INJECTION | 500 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
65 | DISCN | INSULIN PURIFIED PORK | REGULAR ILETIN II (PORK) | N018344 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
66 | DISCN | INSULIN SUSP ISOPHANE PURIFIED PORK | NPH ILETIN II (PORK) | N018345 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
67 | DISCN | INSULIN SUSP PROTAMINE ZINC PURIFIED PORK | PROTAMINE ZINC AND ILETIN II (PORK) | N018346 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
68 | DISCN | INSULIN ZINC SUSP PURIFIED PORK | LENTE ILETIN II (PORK) | N018347 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
69 | DISCN | INSULIN PURIFIED PORK | REGULAR PURIFIED PORK INSULIN | N018381 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
70 | DISCN | INSULIN ZINC SUSP PROMPT PURIFIED PORK | SEMILENTE | N018382 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
71 | DISCN | INSULIN ZINC SUSP PURIFIED PORK | LENTE | N018383 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
72 | DISCN | INSULIN ZINC SUSP PURIFIED BEEF/PORK | LENTARD | N018384 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
73 | DISCN | INSULIN ZINC SUSP EXTENDED PURIFIED BEEF | ULTRALENTE | N018385 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
74 | DISCN | INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF | PROTAMINE ZINC AND ILETIN II | N018476 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
75 | DISCN | INSULIN ZINC SUSP PURIFIED BEEF | LENTE ILETIN II | N018477 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
76 | DISCN | INSULIN PURIFIED BEEF | REGULAR ILETIN II | N018478 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
77 | DISCN | INSULIN SUSP ISOPHANE PURIFIED BEEF | NPH ILETIN II | N018479 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
78 | DISCN | INSULIN SUSP ISOPHANE PURIFIED PORK | NPH PURIFIED PORK ISOPHANE INSULIN | N018623 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | Approved Prior to Jan 1, 1982 | - | - | - | - | - | - | - | |||||
79 | DISCN | INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN | NOVOLIN L | NOVOLIN | N018777 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 8/30/1983 | - | - | - | - | - | - | - | ||||
80 | DISCN | INSULIN RECOMBINANT PURIFIED HUMAN | NOVOLIN R | NOVOLIN | N018778 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 8/30/1983 | - | - | - | - | - | - | - | ||||
81 | DISCN | INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN | NOVOLIN N | NOVOLIN | N019065 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 1/23/1985 | - | - | - | - | - | - | - | ||||
82 | DISCN | INSULIN ZINC SUSP RECOMBINANT HUMAN | HUMULIN L | HUMULIN | N019377 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 9/30/1985 | - | - | - | - | - | - | - | ||||
83 | DISCN | INSULIN RECOMBINANT PURIFIED HUMAN; INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN | NOVOLIN 70/30 | NOVOLIN | N019441 | INJECTABLE | INJECTION | 30 UNITS/ML; 70 UNITS/ML | NOVO NORDISK INC | 7/11/1986 | - | - | - | - | - | - | - | ||||
84 | DISCN | INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN | INSULATARD NPH HUMAN | N019449 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 5/30/1986 | - | - | - | - | - | - | - | |||||
85 | DISCN | INSULIN RECOMBINANT PURIFIED HUMAN | VELOSULIN BR HUMAN | N019450 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 5/30/1986 | - | - | - | - | - | - | - | |||||
86 | DISCN | INSULIN RECOMBINANT HUMAN | HUMULIN BR | HUMULIN | N019529 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 4/28/1986 | - | - | - | - | - | - | - | ||||
87 | DISCN | INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN | HUMULIN U | HUMULIN | N019571 | INJECTABLE | INJECTION | 40 UNITS/ML | ELI LILLY AND CO | 6/10/1987 | - | - | - | - | - | - | - | ||||
88 | DISCN | INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN | HUMULIN U | HUMULIN | N019571 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 6/10/1987 | - | - | - | - | - | - | - | ||||
89 | DISCN | INSULIN RECOMBINANT PURIFIED HUMAN; INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN | MIXTARD HUMAN 70/30 | N019585 | INJECTABLE | INJECTION | 30 UNITS/ML; 70 UNITS/ML | BAYER PHARMACEUTICALS CORP | 3/11/1988 | - | - | - | - | - | - | - | |||||
90 | DISCN | INSULIN ZINC SUSP RECOMBINANT HUMAN | NOVOLIN L | NOVOLIN | N019965 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 6/25/1991 | - | - | - | - | - | - | - | ||||
91 | DISCN | INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN | HUMULIN 50/50 | HUMULIN | N020100 | INJECTABLE | INJECTION | 50 UNITS/ML; 50 UNITS/ML | ELI LILLY AND CO | 4/29/1992 | - | - | - | - | - | - | - | ||||
92 | DISCN | INSULIN LISPRO RECOMBINANT | HUMALOG PEN | HUMALOG | N020563 | INJECTABLE | INJECTION | 100 UNITS/ML | ELI LILLY AND CO | 8/6/1998 | - | - | - | - | - | - | - | ||||
93 | DISCN | INSULIN ASPART RECOMBINANT | NOVOLOG FLEXTOUCH | NOVOLOG | N020986 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 4/23/2004 | - | - | - | - | - | - | - | ||||
94 | DISCN | INSULIN ASPART RECOMBINANT | NOVOLOG INNOLET | NOVOLOG | N020986 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 10/31/2013 | - | - | - | - | - | - | - | ||||
95 | DISCN | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | HUMALOG MIX 75/25 PEN | HUMALOG | N021017 | INJECTABLE | INJECTION | 75 UNITS/ML; 25 UNITS/ML | ELI LILLY AND CO | 12/22/1999 | - | - | - | - | - | - | - | ||||
96 | DISCN | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | HUMALOG MIX 50/50 PEN | HUMALOG | N021018 | INJECTABLE | INJECTION | 50 UNITS/ML; 50 UNITS/ML | ELI LILLY AND CO | 12/22/1999 | - | - | - | - | - | - | - | ||||
97 | DISCN | INSULIN RECOMBINANT HUMAN | VELOSULIN BR | N021028 | INJECTABLE | INJECTION | 100 UNITS/ML | NOVO NORDISK INC | 7/19/1999 | - | - | - | - | - | - | - | |||||
98 | DISCN | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | NOVOLOG MIX 70/30 PENFILL | NOVOLOG | N021172 | INJECTABLE | SUBCUTANEOUS | 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) | NOVO NORDISK INC | 11/1/2001 | - | - | - | - | - | - | - | ||||
99 | DISCN | INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT | NOVOLOG MIX 70/30 PENFILL | NOVOLOG | N021172 | INJECTABLE | SUBCUTANEOUS | 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) | NOVO NORDISK INC | 11/1/2001 | - | - | - | - | - | - | - | ||||
100 | DISCN | INSULIN DETEMIR RECOMBINANT | LEVEMIR FLEXPEN | LEVEMIR | N021536 | INJECTABLE | SUBCUTANEOUS | 300 UNITS/3ML (100 UNITS/ML) | NOVO NORDISK INC | 6/16/2005 | - | - | - | - | - | - | - |